Skip to content
Search

Latest Stories

Study estimates autism affects one in 127 globally

The estimates come from the Global Burden of Diseases (GBD) Study, the largest and most comprehensive ones to assess health loss around the world over time

Study estimates autism affects one in 127 globally

The disorder is associated with repetitive behaviour and affected social skills.

(Photo for representation: iStock)

A STUDY has estimated that one in every 127 people globally, or 6.18 crore individuals, had autism in 2021, with the neurodevelopmental condition featuring among the top 10 causes of non-fatal health burden in youth aged under 20 years.

The disorder is associated with repetitive behaviour and affected social skills. Signs, which can begin to show as early as 12 months of age, include poor non-verbal communication, such as avoiding eye contact and not responding to their name.


Published in the Lancet Psychiatry journal, the results showed that globally, autism cases among men were over twice of those in women -- 1,065 cases for every 100,000 men and 508 for every 100,000 women.

The estimates come from the Global Burden of Diseases (GBD) Study, the largest and most comprehensive ones to assess health loss around the world over time, according to the Institute for Health Metrics and Evaluation, University of Washington, US, which coordinates it.

"An estimated 61.8 million individuals (one in every 127 people) were on the autism spectrum globally in 2021," the authors wrote.

Regions such as high-income Asia Pacific, including Japan, revealed the highest prevalence (1,560 per 100,000 population), while Tropical Latin America and Bangladesh reported the lowest, researchers said.

The findings underscored the importance of early detection and support to autistic young people and their caregivers globally, the authors said.

They also called for efforts to improve accuracy of the study's findings, including a better understanding of how autism prevalence differs with geography.

"The work presented here can guide future research efforts, and importantly, decisions concerning allocation of health services that better address the needs of all autistic individuals," the authors wrote.

(PTI)

More For You

Minorities in England face 'lower prescribing rates for diabetes tech'

The disparity is particularly concerning as approximately 5.8 m people across the UK live with diabetes

iStock

Minorities in England face 'lower prescribing rates for diabetes tech'

Highlights

  • Ethnic minorities are less likely to receive continuous glucose monitors despite having higher diabetes rates.
  • People from minority backgrounds make up 17.5 per cent of populations in areas with below-average device prescribing.
  • Ethnicity and deprivation account for up to 77 per cent of variance in diabetes technology prescribing.

People from ethnic minority backgrounds in England have significantly less access to vital diabetes technology, despite being at greater risk of developing the condition, according to groundbreaking research.

The study, published in Diabetic Medicine, reveals that black and south Asian communities face significantly lower prescribing rates for continuous glucose monitors (CGMs) – devices that help people manage their blood glucose levels more effectively than traditional finger-prick tests.

Keep ReadingShow less